Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GSK-25

Copy Product Info
😃Good
Catalog No. T4488Cas No. 874119-56-9
Alias GSK25

GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).

GSK-25

GSK-25

Copy Product Info
😃Good
Purity: 99.29%
Catalog No. T4488Alias GSK25Cas No. 874119-56-9
GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$39In StockIn Stock
2 mg$54In StockIn Stock
5 mg$84In StockIn Stock
10 mg$119In StockIn Stock
25 mg$180In StockIn Stock
50 mg$286In StockIn Stock
100 mg$478-In Stock
1 mL x 10 mM (in DMSO)$96In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.29%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

GSK-25 AI Summary
GSK-25 exhibits substantial bioactivity, including potent inhibition of human recombinant ROCK1 kinase with an IC50 value of 6.0 nM. It shows moderate inhibition of CYP2C9, CYP2D6, and CYP3A4 enzymes with IC50 values of 2500.0 nM and 5200.0 nM, respectively. Additionally, 513871 efficiently inhibits phenylephrine-induced aortic ring contraction in Sprague-Dawley rats with an IC50 of 256.0 nM and reduces mean arterial pressure by 25.0 mmHg in an anesthetized spontaneous hypertensive rat model at a dose of 30 mg/kg. The compound also demonstrates moderate inhibition of p70S6K and RSK1, with IC50 values of 1000.0 nM and 398.0 nM, respectively. Pharmacokinetic evaluations reveal favorable properties, including a half-life of 105.0 hours in Sprague-Dawley rats and 2.2 hours in monkeys, with moderate to high oral bioavailability (49.0% in rats and 19.0% in monkeys) and moderate clearance and volume of distribution in rats (36.0 mL.min-1.kg-1 and 2.0 L.kg-1). In a PubChem BioAssay qHTS profiling assay, GSK-25 shows a potency of 21117.7 nM against Plasmodium falciparum (DD2) proliferation..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
Targets&IC50
mTOR (p70S6K):1000nM, RSK1:398 nM, ROCK1:7 nM
SynonymsGSK25
Chemical Properties
Molecular Weight513.33
FormulaC24H16Cl2F2N6O
Cas No.874119-56-9
SmilesCC1=C(C(N=C(N1)c1ccnc(Cl)c1)c1ccc(Cl)cc1F)C(=O)Nc1cc2cn[nH]c2cc1F
Relative Density.1.57 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 60 mg/mL (116.88 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.9 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.9481 mL9.7403 mL19.4806 mL97.4032 mL
5 mM0.3896 mL1.9481 mL3.8961 mL19.4806 mL
10 mM0.1948 mL0.9740 mL1.9481 mL9.7403 mL
20 mM0.0974 mL0.4870 mL0.9740 mL4.8702 mL
50 mM0.0390 mL0.1948 mL0.3896 mL1.9481 mL
100 mM0.0195 mL0.0974 mL0.1948 mL0.9740 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GSK-25 | purchase GSK-25 | GSK-25 cost | order GSK-25 | GSK-25 chemical structure | GSK-25 formula | GSK-25 molecular weight